2025-07-08 20:37 ET - News Release

(via TheNewswire)

Edmonton, Alberta – TheNewswire - July 8, 2025 – Innovotech Inc. (TSX-V: IOT) (“Innovotech”, or the “Company”) concluded its annual general and special meeting of shareholders on July 8, 2025. Shareholders voted in favor of all matters, which included the re-election of James Timourian, Karen Farkas, David Tam, Julie Wright, Brad Clark, and Craig Milne as directors of the Company. Shareholders approved the appointment of D&H Group LLP as the Company auditors for the next fiscal year and continued the Omnibus Security Based Compensation Plan first adopted in 2024.

Innovotech also welcomes Arden Tse to the board of directors. Mr. Tse is an Edmonton-based venture capital investor with over 20 years of diverse investment management experience. He currently leads Yaletown Partners' early-stage technology investments in Alberta through the Accelerate Funds II to IV, he specializes in identifying high-potential startups in life sciences and tech.  Mr. Tse holds a BSc and an MBA in Finance from the University of Alberta and is a certified Executive Coach through Royal Roads University.  

In addition, Innovotech announces the departure of two long-serving executives,  Chief Operating Officer Dr. Tyler Boone and Chief Scientific Officer Dr. Patricia Nadworny.  “We thank each of them for their long-term dedicated service and accomplishments over the years with Innovotech”, said Craig Milne, CEO.

 

About Innovotech:

Innovotech Inc. is a diversified Canadian technology company with business operations in a growing portfolio of specialized laboratory services, biotechnology businesses, and proprietary intellectual property. Innovotech Inc. manages several subsidiary companies.  Innovotech Labs Corporation is a contract research organization that owns and provides proprietary devices for antimicrobial testing in multiple applications and commercializes antimicrobial silver solutions. Learn more at www.innovotech.ca . Keystone Labs Inc. is a DEL-accredited lab serving the Canadian pharmaceutical industry and industrial markets. Learn more at www.keystonelabs.ca.  Innovotech Inc. owns a 60% stake in NouLifeSciences Inc., a company holding intellectual property related to antioxidant molecules with potential applications in cosmetics and various medical conditions including neuropathies.  

 

Craig Milne, CEO           Innovotech Inc.

+1-604-239-1819        [email protected]

 

This document may contain forward-looking statements that are predictive in nature and subject to risks and uncertainties that cannot be predicted or quantified; consequently, actual results may differ materially from past results and those expressed or implied by any forward-looking statements. Factors that could cause or contribute to such risks or uncertainties include, but are not limited to: the regulatory environment including the difficulty of predicting regulatory outcomes; changes in the value of the Canadian dollar; the Company’s reliance on a small number of customers including government organizations; fluctuations in operating results; government policies or actions; progress and cost of clinical trials; reliance on key strategic relationships; uncertainty related to intellectual property protection and potential costs associated with its defense; the Company’s exposure to lawsuits and other matters beyond the control of management. Should known or unknown risks or uncertainties materialize, or should management’s assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly make or update any forward- looking statements, except as required by applicable law.

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

###

      

Copyright (c) 2025 TheNewswire - All rights reserved.

© 2025 Canjex Publishing Ltd. All rights reserved.